Avalon Investment & Advisory Catalent, Inc. Transaction History
Avalon Investment & Advisory
- $3.56 Billion
- Q1 2023
A detailed history of Avalon Investment & Advisory transactions in Catalent, Inc. stock. As of the latest transaction made, Avalon Investment & Advisory holds 7,772 shares of CTLT stock, worth $493,366. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,772
Previous 8,224
5.5%
Holding current value
$493,366
Previous $370,000
37.84%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding CTLT
# of Institutions
319Shares Held
114MCall Options Held
571KPut Options Held
2.03M-
Black Rock Inc. New York, NY15.4MShares$975 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$473 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$406 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$287 Million0.14% of portfolio
-
Barclays PLC London, X04.28MShares$272 Million0.07% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $11.4B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...